Sprinklr Announces Third Quarter Fiscal 2025 Results

Go back to Sprinklr Announces Third Quarter Fiscal 2025 Results
Cardium Therapeutics, Inc. (NYSE: CXM) Delayed: 7.98 +0.51 (6.83%)
Previous Close $7.47    52 Week High $1.44 
Open $7.59    52 Week Low $0.06 
Day High $8.04    P/E N/A 
Day Low $7.56    EPS $-1.24 
Volume 2,859,230